Recent Publications by Takedahp: |  |
Spironolactone effective hypertension in the elderly due to 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) impairment: contributory role of determining serum cortisol/cortisone ratio as a marker of 11beta-HSD2 activity.
Two elderly patients with mineralocorticoid excess state due to 11... | 2nd October, 2009
| Department of Internal Medicine, Kizuyabashi Takeda Hospital, Kyoto.
| Intern Med. 2008;47(24):2157-64. Epub 2008 Dec 15.
|
John Auer and Auer rods; controversies revisited.
John Auer first described needle or rod-shaped intracytoplasmic inclusion... | 7th April, 2009
| The Center for Hematological Diseases, Takeda General Hospital, Japan.
| Leuk Res. 2009 May;33(5):614-6. Epub 2008 Oct 22.
DOI Direct Link |
Historical review. The light and shadow of Paul Kaznelson: his life and contribution to hematology.
Paul Kaznelson is credited with describing the first case of pure red cell... | 13th November, 2008
| Center for Hematological Diseases, Takeda General Hospital, 28-1
| Ann Hematol. 2008 Nov;87(11):877-9. Epub 2008 Jul 22.
DOI Direct Link |
Two elderly patients with mineralocorticoid excess due to 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) impairment.
A 75-year-old woman had a low circulating level of aldosterone, despite... | 12th June, 2008
| Department of Internal Medicine, Kizuyabashitakeda Hospital, Kyoto, Japan.
| Intern Med. 2008;47(7):631-6. Epub 2008 Apr 1.
|
Evolving new treatment for myelodysplastic syndromes.
Over the last several years, there has been substantial progress in the... | 12th March, 2008
| Takeda General Hospital, Fushimi-ku, Kyoto 601-1495, Japan.
| Int J Hematol. 2007 Nov;86(4):297-300.
DOI Direct Link |
→View more Takedahp research publications. |
This page has been viewed 161 times since April 2007, the link to the organisation's website has been followed 38 times
